You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hairy cell leukemia (HCL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

    Active, not recruiting
    Has Results
    • Hairy Cell Leukemia
    • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 13, 2022

    Hairy Cell Leukemia Patients

    Not yet recruiting
    • Hairy Cell Leukemia
      • (no location specified)
      May 5, 2023

      Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

      Recruiting
      • Hairy Cell Leukemia
      • Low dose vemurafenib plus rituximab
      • La Jolla, California
        Scripps MD Anderson Cancer Center
      May 19, 2022

      Moxetumomab Pasudotox-tdfk (LUMOXITI)

      Recruiting
      • Hairy Cell Leukemia
        • Pueblo, Colorado
        • +1 more
        Aug 17, 2022

        Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

        Active, not recruiting
        • Hairy Cell Leukemia
        • +2 more
        • New Haven, Connecticut
        • +8 more
        Feb 7, 2022

        Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

        Not yet recruiting
        • Relapsed/Refractory Waldenstrom Macroglobulinemia
        • +3 more
        • Brexucabtagene Autoleucel
        • +2 more
        • (no location specified)
        Sep 8, 2022

        CLL, SLL, HCL Trial in Dresden

        Recruiting
        • CLL
        • +7 more
          • Dresden, Sachsen, Germany
            BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
          Apr 29, 2022

          Hairy Cell Leukemia Patient Data Registry

          Recruiting
          • Leukemia, Other
            • Columbus, Ohio
              Ohio State University Comprehensive Cancer Center
            Apr 1, 2021

            CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

            Recruiting
            • CLL/SLL
            • +6 more
            • Cincinnati, Ohio
            • +2 more
            May 7, 2022

            Patients Previously Treated WithMustang Bio CAR-T Cell

            Enrolling by invitation
            • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
            • +10 more
            • Prior MB-102 CAR-T cell investigational product.
            • Prior MB-106 CAR-T cell investigational product.
            • Duarte, California
            • +4 more
            Dec 8, 2022

            Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

            Recruiting
            • Recurrent Acute Leukemia
            • +16 more
            • Duarte, California
              City of Hope Medical Center
            Nov 22, 2022

            Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

            Recruiting
            • Leukemia, Acute Myeloid
            • +7 more
            • Denver, Colorado
            • +4 more
            Aug 29, 2022

            Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

            Active, not recruiting
            • Adult Grade III Lymphomatoid Granulomatosis
            • +23 more
            • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
            • +2 more
            • Duarte, California
              City of Hope Medical Center
            Jan 4, 2023

            Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

            Recruiting
            • Acute Adult T-Cell Leukemia/Lymphoma
            • +3 more
            • Atlanta, Georgia
            • +13 more
            Jan 26, 2023

            Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)

            Completed
            Has Results
            • Leukemia
            • +2 more
            • Boston, Massachusetts
            • +14 more
            Nov 23, 2022

            High Risk Acute Lymphoblastic Leukemia Trial in Aurora (Hybrid Closed Loop System)

            Recruiting
            • High Risk Acute Lymphoblastic Leukemia
            • Hybrid Closed Loop System
            • Aurora, Colorado
              Children's Hospital Colorado
            Apr 7, 2022

            Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

            Not yet recruiting
            • Leukemia
            • +2 more
            • Houston, Texas
              M D Anderson Cancer Center
            Aug 28, 2023

            B-cell Chronic Lymphoid Malignancies Markers

            Recruiting
            • Chronic Lymphocytic Leukemia
            • +5 more
              • Strasbourg, France
                Hematology Laboratory - Strasbourg University Hospitals
              Jul 2, 2021

              Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

              Recruiting
              • Acute Myeloid Leukemia
              • +3 more
              • Birmingham, Alabama
              • +8 more
              Jan 24, 2023

              Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

              Active, not recruiting
              • Accelerated Phase Chronic Myelogenous Leukemia
              • +125 more
              • tetanus-CMV fusion peptide vaccine
              • laboratory biomarker analysis
              • Duarte, California
                City of Hope Medical Center
              Feb 28, 2022

              Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

              Active, not recruiting
              • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
              • +6 more
              • Houston, Texas
                M D Anderson Cancer Center
              Dec 2, 2022

              Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

              Completed
              • Anemia
              • +13 more
              • Portland, Oregon
                OHSU Knight Cancer Institute
              Apr 29, 2021